Serum Calcium And Phosphateleveelsin Patients With Chronic Myeloid Leukemia Taking Different Dose of Tyrosine Kinase Inhibitors

Objective: chronic myeloid leukemia (CML) is a myeloproliferative confusion characterized by the occurrence of an acquired mutation which affect the hematopoietic stem cell, treatment of CML with tyrosine kinase inhibitors (TKI) has resulted in high response rates compared to the interferon alpha a...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Bassam Francis Matti, Shahla'a Fadhil Sabir, Maysaa Ali Abdul Khaleq, Marwah Hasan Al kaabi
Formato:	Artigo
Idioma:	Inglês
Publicado em:	College of Pharmacy / Mustansiriyah University 2018-03-01
Colecção:	Al-Mustansiriyah Journal of Pharmaceutical Sciences
Assuntos:	chronic myeloid leukemia serum calcium and phosphatelevels tyrosin kinase inhibitors
Acesso em linha:	https://ajps.uomustansiriyah.edu.iq/index.php/AJPS/article/view/77
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!